Intravenous glutamine for severe acute pancreatitis: A meta-analysis

doi:10.5492/wjccm.v2.i1.4

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5912)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

434

HTML

2939

Figures (1-2)

258

Tables (1-1)

245

Sum=3876

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1024

Download

1012

Sum=2036

Feb 4, 2013 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Crit Care Med. Feb 4, 2013; 2(1): 4-8
Published online Feb 4, 2013. doi: 10.5492/wjccm.v2.i1.4

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram of the study selection process.

Open in New Tab Full Size Figure Download Figure

Figure 2 Effect of glutamine dipeptide. A: On mortality for severe acute pancreatitis (SAP); B: On length of hospital stay for SAP; C: On rate of complications for SAP.

Citation: Zhong X, Liang CP, Gong S. Intravenous glutamine for severe acute pancreatitis: A meta-analysis. World J Crit Care Med 2013; 2(1): 4-8
URL: https://www.wjgnet.com/2220-3141/full/v2/i1/4.htm
DOI: https://dx.doi.org/10.5492/wjccm.v2.i1.4